Eve Marder is a University Professor and the Victor and Gwendolyn Beinfield Professor of Neuroscience at Brandeis University. At Brandeis, Marder is also a member of the Volen National Center for Complex Systems. Dr. Marder is known for her pioneering work on small neuronal networks which her team has interrogated via a combination of complementary experimental and theoretical techniques.
Lei Wang, Ph.D. The Regents of the University of California, School of Pharmacy
Lei Wang received BS and MS from Peking University mentored by Zhongfan Liu, and PhD from UC Berkeley mentored by Peter G. Schultz. His graduate research resulted in the first expansion of the genetic code to include unnatural amino acids (Uaas) in 2001, for which he was awarded the Young Scientist Award by the journal Science. After postdoctoral training with Roger Y. Tsien, Wang started his group at the Salk Institute in 2005, and moved to UCSF in 2014.
Jennifer Phillips-Cremins, Ph.D. University of Pennsylvania The School of Engineering and Applied Sciences Department of Bioengineering
Jennifer E. Phillips-Cremins, Ph.D. is a tenured associate professor and Deans’ Faculty Fellow in Engineering and Medicine in the Departments of Genetics and Bioengineering at the University of Pennsylvania. During her Ph.D. candidacy at Georgia Institute of Technology, Dr. Cremins was funded by an NSF Graduate Research Fellowship to develop transcription factor-based genetic engineering strategies for the direct conversion of dermal fibroblasts into osteoblasts.
Bradley J. Aimone, Ph.D. Sandia National Laboratories
An underappreciated challenge of understanding the health implications of neural dynamics is the wide range of temporal and spatial scales in the brain. Neurological and mental health disorders often manifest themselves over months and years, while most neuroscience research focuses on dynamics over shorter timescales. This is especially a challenge for computational approaches, in which neural simulations are often limited to several seconds due to compute costs, greatly limiting their use for understanding fundamental neuroscience and health.
Christian Happi, Ph.D. Redeemer's University Redemption City, Nigeria
I have the expertise and skills, leadership and motivation necessary to successfully conduct and oversee health research projects in West Africa. I have a broad background in molecular biology and genomics with application in infectious diseases, including malaria, Lassa fever, Ebola virus disease and HIV. Of my career accomplishments to date, the most meaningful was my use of genomics technologies for early diagnosis and confirmation (within 6 hours) of Ebola virus disease (EVD) in Nigeria.
Mariana Kaplan, M.D., joined NIAMS as Chief of the Systemic Autoimmunity Branch in 2013. She is also Deputy Scientific Director at NIAMS. Before her appointment, she was a Professor of Medicine in the Division of Rheumatology at the University of Michigan. Dr. Kaplan obtained her medical degree at the National Autonomous University of Mexico and did her Internal Medicine Residency at the National Institute of Medical Sciences and Nutrition in Mexico City. Dr.
Born and raised in India, Dr. Sudha Chakrapani came to the United States after completing her master’s degree in biomedical engineering. She received her Ph.D. in physiology and biophysics from the University at Buffalo and went on to complete postdoctoral positions at the University of Virginia and the University of Chicago. In 2010, she joined the faculty at Case Western Reserve University in Cleveland, Ohio, in the department of physiology and biophysics.
William M. (Bil) Clemons, Jr. Ph.D, California Institute of Technology, Division of Chemistry and Chemical Engineering
Professor Bil Clemons received his PhD from the University of Utah working under Prof. Venki Ramakrishnan. During this time he spent two years as a visiting scientist at the Laboratory of Molecular Biology in Cambridge, England. The most notable achievement during his graduate work was that he was part of the team that solved the first atomic resolution structure of a small ribosomal subunit. This work led to a fundamental understanding of the translation of the genetic code and provided molecular details of the mechanism of a number of antibiotics.
Dr. Jason McLellan researches viral and bacterial proteins, and his work to understand how these proteins are structured and how they function has factored into the development of vaccines and potential treatments for deadly pathogens that have impacted the lives of billions of people. He is one of the inventors of a way to engineer a key protein in coronaviruses for use in vaccines. The technology his team developed can be found in many leading vaccines against COVID-19 (Pfizer/BioNTech, Moderna, Johnson & Johnson, and Novavax).
This page was last updated on Wednesday, July 10, 2024